Alzheimer’s disease is the most common cause of dementia, affecting millions worldwide. It often begins silently, with subtle memory lapses, reduced concentration, and changes in mood or behavior — symptoms that are frequently overlooked or attributed to normal aging.
However, early diagnosis is critical. Detecting Alzheimer’s-related cognitive decline in its earliest stages gives individuals and families a chance to take action, plan ahead, and benefit from available treatments and support strategies.
Most current diagnostic approaches rely on subjective questionnaires, memory tests, or advanced imaging techniques like MRI and PET scans. While helpful, these tools often detect changes after significant brain damage has already occurred.
Additionally, cognitive testing can be influenced by, language or cultural background, educational level, mood disturbances or fatigue at the time of testing
This is where Braintrip-NeuroAI offers a powerful alternative. Braintrip NeuroAI offers a state-of-the-art, non-invasive system that uses brainwave (EEG) analysis powered by artificial intelligence to detect early signs of cognitive decline with exceptional accuracy.
Braintrip NeuroAI analyzes your brain's electrical activity, detecting the subtle “fingerprints” of Alzheimer’s disease long before traditional tools can. The entire process is quick, painless, and results are available within minutes. Results are not affected by language, culture, or education with 95% accuracy, 96% specificity, 88% sensitivity.
Braintrip NeuroAI may beneficial for early cognitive screening for individuals who experience:
- Frequent forgetfulness or memory lapses
- Difficulty focusing or making decisions
- Trouble with familiar tasks or directions
- Family history of Alzheimer’s or other dementias
- Cognitive concerns after COVID-19 or head injury
Early diagnosis is of great importance because it allows individuals and families to take action before significant brain damage occurs. Identification of Alzheimer’s in its early stages means that treatment can begin sooner, potentially slowing the progression and preserving quality of life. It also opens access to essential support services, including cognitive therapies, lifestyle interventions, and social programs designed to maintain independence of the people who are affected.